TNNI3 and heart failure: Thin filament mutations associated with HCM are predominantly located in TPM1 (α-tropomyosin), TNNT2 (TnT), TNNI3 (TnI), and ACTC1, resulting in a phenotypically distinct class of patients with increased risks for cardiac dysfunction and heart failure (Coppini et al. 2014).